Search result for TAKEDA CO
- Takeda Co. planning to sell its OTC medicine unit to U.S Blackstone Group Inc.
- Takeda plans on selling the same for around $2.9 billion.
- Takeda aims to reduce its debt of $5.86 billion after its purchase of Shire Plc.
- Takeda pharmaceutical co. raised its net profit outlook for this year.
- The drug-making company revised its bottom-line outlook to $880 million.
- It also reported an operating profit outlook to $374 million.